Lumigan

Eyelash, Glaucoma, Open Angle Glaucoma + 1 more
Treatment
1 FDA approval
18 Active Studies for Lumigan

What is Lumigan

BimatoprostThe Generic name of this drug
Treatment SummaryBimatoprost, also known as Latisse or Lumigan, is a drug used to treat conditions like ocular hypertension and glaucoma. It is administered in both an eye drop solution and implant form. Bimatoprost was approved by the FDA in 2001 and is also used to promote eyelash growth. It is a prostamide, which is a synthetic form of prostaglandin.
Lumiganis the brand name
image of different drug pills on a surface
Lumigan Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Lumigan
Bimatoprost
2001
25

Approved as Treatment by the FDA

Bimatoprost, otherwise called Lumigan, is approved by the FDA for 1 uses like Eyelash .
Eyelash

Effectiveness

How Lumigan Affects PatientsHigh eye pressure is dangerous and can lead to vision loss. People with ocular hypertension or glaucoma can have very high levels of eye pressure. Bimatoprost helps to lower eye pressure quickly and reduce the risk of vision loss. It can also cause changes in the color or thickness of the eyelids, iris, and eyelashes. If only one eye is treated with bimatoprost, it may look different than the other eye. Patients should be aware of these potential side effects.
How Lumigan works in the bodyBimatoprost mimics the effects of a natural chemical called prostaglandin F2α. This chemical helps to reduce the pressure in your eye, which protects your optic nerve from damage. Bimatoprost makes it easier for fluid in your eye to drain out, which reduces the pressure. It does not affect the amount of fluid in the eye, only how easily it can flow out.

When to interrupt dosage

The suggested measure of Lumigan is contingent upon the recognized condition, such as Open Angle Glaucoma, Increased Intra Ocular Pressure (IOP) and Eyelash. The amount of dosage alters, in line with the technique of delivery presented in the table below.
Condition
Dosage
Administration
Ocular Hypertension
, 0.3 mg/mL, 0.1 mg/mL, 0.03 %, 0.01 %, 0.003 mg/mL, 0.01 mg
, Solution / drops, Ophthalmic, Solution / drops - Ophthalmic, Solution, Solution - Ophthalmic, Topical, Solution - Topical, Implant
Eyelash
, 0.3 mg/mL, 0.1 mg/mL, 0.03 %, 0.01 %, 0.003 mg/mL, 0.01 mg
, Solution / drops, Ophthalmic, Solution / drops - Ophthalmic, Solution, Solution - Ophthalmic, Topical, Solution - Topical, Implant
Glaucoma
, 0.3 mg/mL, 0.1 mg/mL, 0.03 %, 0.01 %, 0.003 mg/mL, 0.01 mg
, Solution / drops, Ophthalmic, Solution / drops - Ophthalmic, Solution, Solution - Ophthalmic, Topical, Solution - Topical, Implant
Open Angle Glaucoma
, 0.3 mg/mL, 0.1 mg/mL, 0.03 %, 0.01 %, 0.003 mg/mL, 0.01 mg
, Solution / drops, Ophthalmic, Solution / drops - Ophthalmic, Solution, Solution - Ophthalmic, Topical, Solution - Topical, Implant

Warnings

There are 20 known major drug interactions with Lumigan.
Common Lumigan Drug Interactions
Drug Name
Risk Level
Description
Acebutolol
Minor
Bimatoprost may increase the hypotensive activities of Acebutolol.
Aliskiren
Minor
Bimatoprost may increase the hypotensive activities of Aliskiren.
Ambrisentan
Minor
Bimatoprost may increase the hypotensive activities of Ambrisentan.
Angiotensin 1-7
Minor
Bimatoprost may increase the hypotensive activities of Angiotensin 1-7.
Azilsartan medoxomil
Minor
Bimatoprost may increase the hypotensive activities of Azilsartan medoxomil.
Lumigan Toxicity & Overdose RiskThere is not enough information to provide a full description of the effects of overdosing on bimatoprost. If an overdose occurs, supportive symptomatic treatment should be provided.
image of a doctor in a lab doing drug, clinical research

Lumigan Novel Uses: Which Conditions Have a Clinical Trial Featuring Lumigan?

34 active trials are currently evaluating the potential of Lumigan in reducing Ocular Hypertension, Intra Ocular Pressure (IOP) and enhancing Eyelash growth.
Condition
Clinical Trials
Trial Phases
Glaucoma
0 Actively Recruiting
Open Angle Glaucoma
12 Actively Recruiting
Phase 3, Not Applicable, Phase 2, Phase 4, Phase 1
Eyelash
0 Actively Recruiting
Ocular Hypertension
11 Actively Recruiting
Phase 3, Phase 4, Phase 1, Phase 2, Not Applicable

Lumigan Reviews: What are patients saying about Lumigan?

5Patient Review
9/1/2021
Lumigan for Increased Pressure in the Eye
I developed hypertension and severe right shoulder and arm pain after 3 weeks of administering the drops into my right eye. Both urgent care doctor and ophthalmologist say there is no causal relationship, but I, and apparently others disagree. Stopped 2 weeks ago and symptoms very slowly resolving. How long before I am back to normal?
5Patient Review
2/17/2022
Lumigan for Wide-Angle Glaucoma
This medication has been really effective in reducing my eye pressure. However, I have experienced some strange side effects like ear congestion and swollen lymph nodes on the left side of my body.
5Patient Review
1/3/2016
Lumigan for Increased Pressure in the Eye
5Patient Review
2/19/2016
Lumigan for Wide-Angle Glaucoma
After using this product, my eyes were red and bloodshot. It looked like I had been on a bender. This product did not help with pressure at all.
4.7Patient Review
4/9/2016
Lumigan for Increased Pressure in the Eye
I've been using Lumigan for over a year and a half now to treat my glaucoma. It's been effective in reducing the pressure in my eyes, though I did have to start using another drop along with it to get the full effect. For side effects, I had red and irritated eyes for the first few weeks but that subsided eventually. Another thing I noticed was that my eyelashes started growing more pronouncedly from about the third month on wards.
View All Reviews
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about lumigan

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is Lumigan the same as Latisse?

"Latisse is a solution that is used to lower pressure in the eyes. This solution also helps to grow eyelashes. This solution is also known as bimatoprost ophthalmic solution."

Answered by AI

What is a common side effect of Lumigan?

"cause burning, stinging, or a gritty sensation in your eye

If you experience any of the following symptoms, you may have an eye infection: pain, redness, itching, swelling, increased sensitivity to light, burning, stinging, or gritty sensation."

Answered by AI

Does Lumigan stop glaucoma?

"Lumigan can help to lower the pressure in your eye, and is often the first choice for treating glaucoma. However, it is worth noting that Lumigan can cause changes to your eyelashes and eye color."

Answered by AI

What does Lumigan do for the eyes?

"Bimatoprost is used to lower pressure in the eye caused by glaucoma or other eye diseases. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure."

Answered by AI

Clinical Trials for Lumigan

Have you considered Lumigan clinical trials? We made a collection of clinical trials featuring Lumigan, we think they might fit your search criteria.
Have you considered Lumigan clinical trials? We made a collection of clinical trials featuring Lumigan, we think they might fit your search criteria.
Have you considered Lumigan clinical trials? We made a collection of clinical trials featuring Lumigan, we think they might fit your search criteria.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top